ABSTRACT
The likely outcome of globally participative norm-setting will be a new Global Enforcement Organization for Xenotransplantation, abbreviated GEOX. The role of GEOX in xenotransplantation would include certification that xenograft herds and transplant centers complied with Asilomar-type risk isolation and containment rules. In order to carry out this role, in a global environment that includes many countries without effective health care systems, GEOX must assume responsibility for emerging disease surveillance in such countries. Such a responsibility can only be accomplished by tasking GEOX with the frank provision of a basic health care capability in those countries.
